Hält derzeit eine Position bei Syndax Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Scientific Officer | Syndax Pharmaceuticals Inc | 1. September 2016 - |
Chief Technology Officer | Syndax Pharmaceuticals Inc | 1. November 2013 - 1. September 2016 |
Vice President of Translational Medicine, Founder | Syndax Pharmaceuticals Inc | 1. Januar 2012 - 1. Oktober 2013 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-02-17 | 2023-02-15 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
17.428
-100.0%
25,84450.404 USD |
17.428 -100.0% | 25,84 | 450.404 USD | |
2023-02-17 | 2023-02-15 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
7.572
-100.0%
25,84195.688 USD |
7.572 -100.0% | 25,84 | 195.688 USD | |
2023-02-03 | 2023-02-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Verkauf |
69
-100.0%
28,431.962 USD |
69 -100.0% | 28,43 | 1.962 USD | |
2022-12-02 | 2022-12-02 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
17.200
-98.5%
25,05430.936 USD |
17.200 -98.5% | 25,05 | 430.936 USD | |
2022-12-02 | 2022-12-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
4.028
-93.8%
25,01100.746 USD |
4.028 -93.8% | 25,01 | 100.746 USD | |
2022-12-02 | 2022-12-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
3.772
-93.4%
25,0194.343 USD |
3.772 -93.4% | 25,01 | 94.343 USD | |
2022-08-26 | 2022-08-24 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
2.154
-89.0%
25,0453.927 USD |
2.154 -89.0% | 25,04 | 53.927 USD | |
2022-08-26 | 2022-08-24 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
22.846
-98.9%
25,04571.966 USD |
22.846 -98.9% | 25,04 | 571.966 USD | |
2022-02-03 | 2022-02-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Verkauf |
1.412
-100.0%
16,6523.510 USD |
1.412 -100.0% | 16,65 | 23.510 USD | |
2020-11-25 | 2020-11-23 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Verkauf |
16.334
-100.0%
22,89373.924 USD |
16.334 -100.0% | 22,89 | 373.924 USD | |
2020-11-25 | 2020-11-23 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Verkauf |
7.954
-32.7%
23,58187.594 USD |
7.954 -32.7% | 23,58 | 187.594 USD | |
2020-11-25 | 2020-11-23 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Verkauf |
5.684
-19.0%
23,33132.603 USD |
5.684 -19.0% | 23,33 | 132.603 USD |